Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating

Journal of Medicinal Chemistry
2020.0

Abstract

Modulators can be designed to stabilize the inactive and active states of ion channels, but whether intermediate (IM) states of channel gating are druggable remains underexplored. In this study, using molecular dynamics simulations of the TWIK-related potassium channel 1 (TREK-1) channel, a two-pore domain potassium channel, we captured an IM state during the transition from the down (inactive) state to the up (active-like) state. The IM state contained a druggable allosteric pocket that was not present in the down or up state. Drug design targeting the pocket led to the identification of the TKIM compound as an inhibitor of TREK-1. Using integrated methods, we verified that TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state. Overall, this study identified an allosteric ligand-binding site and a new mechanistic inhibitor for TREK-1, suggesting that IM states of ion channels may be promising druggable targets for use in discovering allosteric modulators.

Knowledge Graph

Similar Paper

Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating
Journal of Medicinal Chemistry 2020.0
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K<sup>+</sup>Channel 1). A Novel Therapeutic Target?
Journal of Medicinal Chemistry 2016.0
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K<sup>+</sup>Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity
Journal of Medicinal Chemistry 2017.0
TREK Channel Family Activator with a Well-Defined Structure–Activation Relationship for Pain and Neurogenic Inflammation
Journal of Medicinal Chemistry 2020.0
The functionally relevant site for paxilline inhibition of BK channels
Proceedings of the National Academy of Sciences 2020.0
TASK Channels Pharmacology: New Challenges in Drug Design
Journal of Medicinal Chemistry 2019.0
Pharmacological Effects of Imidacloprid and Its Related Compounds on the Nicotinic Acetyicholine Receptor with Its Ion Channel from the &lt;i&gt;Torpedo&lt;/i&gt; Electric Organ
Journal of Pesticide Science 1995.0
Design, Synthesis, and Pharmacological Evaluation of Conformationally Constrained Analogues of N,N‘-Diaryl- and N-Aryl-N-aralkylguanidines as Potent Inhibitors of Neuronal Na<sup>+</sup> Channels
Journal of Medicinal Chemistry 1998.0
Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype
Bioorganic &amp; Medicinal Chemistry Letters 2022.0
Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors
ACS Medicinal Chemistry Letters 2021.0